These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

70 related items for PubMed ID: 19797941

  • 1. Bacitracin-sensitive aminopeptidase(s) degradation of methionine(5)-enkephalin by human brain putamen and hippocampus preparations: inhibition by phenothiazine drugs.
    Mosnaim AD, Saavedra R, Wolf ME.
    Am J Ther; 2009; 16(6):512-6. PubMed ID: 19797941
    [Abstract] [Full Text] [Related]

  • 2. In vitro human plasma leucine(5)-enkephalin degradation is inhibited by a select number of drugs with the phenothiazine molecule in their chemical structure.
    Mosnaim AD, Puente J, Saavedra R, Diamond S, Wolf ME.
    Pharmacology; 2003 Jan; 67(1):6-13. PubMed ID: 12444298
    [Abstract] [Full Text] [Related]

  • 3. Degradation kinetics of methionine5-enkephalin by select brain areas from patients with chronic schizophrenia.
    Mosnaim AD, Nguyen TD, Puente J, Wolf ME.
    Am J Ther; 2008 Jan; 15(2):126-30. PubMed ID: 18356632
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of human plasma leucine5-enkephalin aminopeptidase hydrolysis by various endogenous peptides and a select number of clinically used drugs.
    Mosnaim AD, Puente J, Ranade V, Hoang C, Wolf ME.
    Am J Ther; 2004 Jan; 11(6):459-65. PubMed ID: 15543085
    [Abstract] [Full Text] [Related]

  • 5. In vitro methionine5-enkephalin degradation kinetics by human brain preparations.
    Mosnaim AD, Nguyen TD, Tse R, Puente J, Couceyro P, Wolf ME.
    Neurochem Res; 2008 Jan; 33(1):81-6. PubMed ID: 17676390
    [Abstract] [Full Text] [Related]

  • 6. Characterization of aminopeptidases responsible for inactivating endogenous (Met5)enkephalin in brain slices using peptidase inhibitors and anti-aminopeptidase M antibodies.
    Giros B, Gros C, Solhonne B, Schwartz JC.
    Mol Pharmacol; 1986 Mar; 29(3):281-7. PubMed ID: 2869404
    [Abstract] [Full Text] [Related]

  • 7. Pulmonary metabolism of exogenous enkephalins in isolated perfused rat lungs.
    Gillespie MN, Krechniak JW, Crooks PA, Altiere RJ, Olson JW.
    J Pharmacol Exp Ther; 1985 Mar; 232(3):675-81. PubMed ID: 2983067
    [Abstract] [Full Text] [Related]

  • 8. Neuropeptide metabolism on intact, regional brain slices: effect of dopaminergic agents on substance P, cholecystokinin and Met-enkephalin degradation.
    Waters SM, Konkoy CS, Davis TP.
    J Pharmacol Exp Ther; 1995 Aug; 274(2):783-9. PubMed ID: 7543572
    [Abstract] [Full Text] [Related]

  • 9. Degradation of enkephalins by rat lymphocyte and purified rat natural killer cell surface aminopeptidases.
    Amoscato AA, Spiess RR, Sansoni SB, Herberman RB, Chambers WH.
    Brain Behav Immun; 1993 Jun; 7(2):176-87. PubMed ID: 8347898
    [Abstract] [Full Text] [Related]

  • 10. Degradation kinetics of methionine5-enkephalin by cerebrospinal fluid: in vitro studies.
    Mosnaim AD, Chuang F, Wolf ME.
    Am J Ther; 2011 Jan; 18(1):9-13. PubMed ID: 20838201
    [Abstract] [Full Text] [Related]

  • 11. Inactivation of enkephalin by brain enzymes.
    Vogel Z, Altstein M.
    Prog Biochem Pharmacol; 1980 Jan; 16():49-59. PubMed ID: 7003599
    [Abstract] [Full Text] [Related]

  • 12. Angiotensin-converting enzyme inhibitors potentiate the analgesic activity of [Met]-enkephalin-Arg6-Phe7 by inhibiting its degradation in mouse brain.
    Norman JA, Autry WL, Barbaz BS.
    Mol Pharmacol; 1985 Dec; 28(6):521-6. PubMed ID: 3001497
    [Abstract] [Full Text] [Related]

  • 13. Enkephalin degradation in the guinea-pig ileum: effect of aminopeptidase inhibitors, puromycin and bestatin.
    Cohen ML, Geary LE, Wiley KS.
    J Pharmacol Exp Ther; 1983 Feb; 224(2):379-85. PubMed ID: 6822962
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of enkephalin degradation attenuated stress-induced motor suppression (conditioned suppression of motility).
    Nabeshima T, Katoh A, Kameyama T.
    J Pharmacol Exp Ther; 1988 Jan; 244(1):303-9. PubMed ID: 3422094
    [Abstract] [Full Text] [Related]

  • 15. Decreased plasma methionine-enkephalin levels in cluster headache patients.
    Mosnaim AD, Maturana P, Puente J, Wolf ME.
    Am J Ther; 2012 May; 19(3):174-9. PubMed ID: 22487772
    [Abstract] [Full Text] [Related]

  • 16. Effect of some peptidase inhibitors on exogenous and endogenous opioid actions in guinea-pig ileum.
    Ozaki M, Miyamoto Y, Kishioka S, Masuda Y, Yamamoto H.
    Biol Pharm Bull; 1994 Jan; 17(1):62-9. PubMed ID: 8148819
    [Abstract] [Full Text] [Related]

  • 17. Regional metabolism of Met-enkephalin and cholecystokinin on intact ratbrain slices: characterization of specific peptidases.
    Konkoy CS, Davis TP.
    J Neurochem; 1995 Dec; 65(6):2773-82. PubMed ID: 7595577
    [Abstract] [Full Text] [Related]

  • 18. Effect of peptidases at the blood brain barrier on the permeability of enkephalin.
    Brownson EA, Abbruscato TJ, Gillespie TJ, Hruby VJ, Davis TP.
    J Pharmacol Exp Ther; 1994 Aug; 270(2):675-80. PubMed ID: 7915319
    [Abstract] [Full Text] [Related]

  • 19. Almost complete protection from [Met5]-enkephalin-Arg6-Gly7-Leu8 (Met-enk-RGL) hydrolysis in membrane preparations by the combination of amastatin, captopril and phosphoramidon.
    Hiranuma T, Iwao K, Kitamura K, Matsumiya T, Oka T.
    J Pharmacol Exp Ther; 1997 May; 281(2):769-74. PubMed ID: 9152384
    [Abstract] [Full Text] [Related]

  • 20. Phenothiazine molecule provides the basic chemical structure for various classes of pharmacotherapeutic agents.
    Mosnaim AD, Ranade VV, Wolf ME, Puente J, Antonieta Valenzuela M.
    Am J Ther; 2006 May; 13(3):261-73. PubMed ID: 16772768
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.